| IL-33 is a crucial amplifier of innate rather than acquired immunity K Oboki, T Ohno, N Kajiwara, K Arae, H Morita, A Ishii, A Nambu, T Abe, ... Proceedings of the National Academy of Sciences 107 (43), 18581-18586, 2010 | 773 | 2010 |
| IL-33 can promote survival, adhesion and cytokine production in human mast cells M Iikura, H Suto, N Kajiwara, K Oboki, T Ohno, Y Okayama, H Saito, ... Laboratory investigation 87 (10), 971-978, 2007 | 456 | 2007 |
| Th17 and allergy K Oboki, T Ohno, H Saito, S Nakae Allergology International 57 (2), 121-134, 2008 | 412 | 2008 |
| IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcεRI signals LH Ho, T Ohno, K Oboki, N Kajiwara, H Suto, M Iikura, Y Okayama, ... Journal of Leucocyte Biology 82 (6), 1481-1490, 2007 | 363 | 2007 |
| An interleukin-33-mast cell-interleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T cell numbers H Morita, K Arae, H Unno, K Miyauchi, S Toyama, A Nambu, K Oboki, ... Immunity 43 (1), 175-186, 2015 | 298 | 2015 |
| IL-33 and IL-33 receptors in host defense and diseases K Oboki, T Ohno, N Kajiwara, H Saito, S Nakae Allergology International 59 (2), 143-160, 2010 | 269 | 2010 |
| IL-33–mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen–induced allergic airway inflammation S Kamijo, H Takeda, T Tokura, M Suzuki, K Inui, M Hara, H Matsuda, ... The Journal of Immunology 190 (9), 4489-4499, 2013 | 201 | 2013 |
| Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages T Ohno, K Oboki, N Kajiwara, E Morii, K Aozasa, RA Flavell, K Okumura, ... The Journal of Immunology 183 (12), 7890-7897, 2009 | 182 | 2009 |
| Three-phase bridge power block module type auxiliary resonant AC link snubber-assisted soft switching inverter for distributed AC power supply H Iyomori, S Nagai, S Sato, T Ohno, M Yoshida, M Nakaoka The 25th International Telecommunications Energy Conference, 2003. INTELEC …, 2003 | 161 | 2003 |
| Interleukin‐33 in allergy T Ohno, H Morita, K Arae, K Matsumoto, S Nakae Allergy 67 (10), 1203-1214, 2012 | 145 | 2012 |
| Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma Y Kondo, T Ohno, N Nishii, K Harada, H Yagita, M Azuma Oral oncology 57, 54-60, 2016 | 128 | 2016 |
| Epithelial cell-derived IL-25, but not Th17 cell-derived IL-17 or IL-17F, is crucial for murine asthma M Suzukawa, H Morita, A Nambu, K Arae, E Shimura, A Shibui, ... The Journal of Immunology 189 (7), 3641-3652, 2012 | 117 | 2012 |
| Role of interleukin-33 in innate-type immune cells in allergy S Nakae, H Morita, T Ohno, K Arae, K Matsumoto, H Saito Allergology International 62 (1), 13-20, 2013 | 113 | 2013 |
| Dietary Lactobacillus-Derived Exopolysaccharide Enhances Immune-Checkpoint Blockade Therapy H Kawanabe-Matsuda, K Takeda, M Nakamura, S Makino, T Karasaki, ... Cancer Discovery 12 (5), 1336-1355, 2022 | 81 | 2022 |
| Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation T Ohno, K Oboki, H Morita, N Kajiwara, K Arae, S Tanaka, M Ikeda, ... PLoS One 6 (4), e18404, 2011 | 70 | 2011 |
| Small interfering RNA against CD86 during allergen challenge blocks experimental allergic asthma Y Asai-Tajiri, K Matsumoto, S Fukuyama, K Kan-o, T Nakano, K Tonai, ... Respiratory research 15, 1-11, 2014 | 46 | 2014 |
| Contributions of Interleukin‐33 and TSLP in a papain‐soaked contact lens‐induced mouse conjunctival inflammation model J Sugita, Y Asada, W Ishida, S Iwamoto, K Sudo, H Suto, T Matsunaga, ... Immunity, Inflammation and Disease 5 (4), 515-525, 2017 | 39 | 2017 |
| Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy N Nishii, H Tachinami, Y Kondo, Y Xia, Y Kashima, T Ohno, S Nagai, L Li, ... Oncotarget 9 (17), 13301, 2018 | 38 | 2018 |
| Galectin-9 enhances cytokine secretion, but suppresses survival and degranulation, in human mast cell line R Kojima, T Ohno, M Iikura, T Niki, M Hirashima, K Iwaya, H Tsuda, ... PloS one 9 (1), e86106, 2014 | 37 | 2014 |
| Development of IL-17-mediated delayed-type hypersensitivity is not affected by down-regulation of IL-25 expression A Ishii, K Oboki, A Nambu, H Morita, T Ohno, N Kajiwara, K Arae, H Sudo, ... Allergology International 59 (4), 399-408, 2010 | 36 | 2010 |
